Global Information Lookup Global Information

Genentech information


Genentech, Inc.
Company typeSubsidiary
IndustryBiotechnology
Founded1976; 48 years ago (1976)
HeadquartersSouth San Francisco, California, United States
Key people
  • Ashley Magargee
  • (interim CEO)[1]
  • Ed Harrington
  • Levi Garraway
  • Stephen Williams
  • Sean Johnston
  • Severin Schwan
  • (Chairman of Genentech Board of Directors, CEO of Roche Group)
  • Anna Batt
  • Aviv Regev[2][3]
ProductsAvastin, Herceptin, Rituxan, Perjeta, Kadcyla, Gazyva, Tarceva, Ocrevus, Polivy, Tecentriq, Xofluza, Hemlibra, Venclexta, Esbriet, Cotellic, Alecensa, Zelboraf, Nutropin, Actemra, Lucentis, Xolair, Activase, Cathflo Activase, Xeloda, Boniva, TNKase, CellCept, Pegasys, Pulmozyme, Tamiflu, Valcyte, Anaprox, Cytovene, EC-Naprosyn, Erivedge, Fuzeon, Invirase, Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical, Zenapax
RevenueIncrease $26.4 billion (2020)[4]
Number of employees
13,539 (July 2021)
ParentRoche
Websitegene.com

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.[5] Historically, the company is regarded as the world's first biotechnology company.[6]

As of July 2021, Genentech employed 13,539 people.[7]

  1. ^ "DEPARTURE OF ALEXANDER HARDY & APPOINTMENT OF ASHLEY MAGARGEE AS INTERIM CHIEF EXECUTIVE OFFICER GENENTECH". Genentech. Retrieved November 3, 2023.
  2. ^ Cite error: The named reference fiercebiotech was invoked but never defined (see the help page).
  3. ^ Cite error: The named reference Press_Regev was invoked but never defined (see the help page).
  4. ^ "Genentech".
  5. ^ "About Us". Gene.com. Archived from the original on August 4, 2014. Retrieved August 22, 2014.
  6. ^ Russo, Eugene (January 2003). "Special Report: The birth of biotechnology". Nature. 421 (6921): 456–457. Bibcode:2003Natur.421..456R. doi:10.1038/nj6921-456a. PMID 12540923. S2CID 4357773.
  7. ^ "Working at Genentech". Great Place to Work. Retrieved November 18, 2021.

and 21 Related for: Genentech information

Request time (Page generated in 0.5753 seconds.)

Genentech

Last Update:

Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche...

Word Count : 3362

Roche

Last Update:

Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary , and the Japanese biotechnology...

Word Count : 5224

Herbert Boyer

Last Update:

co-founder of Genentech. He was professor at the University of California, San Francisco (UCSF) and later served as vice president of Genentech from 1976...

Word Count : 761

Growth hormone

Last Update:

somatotropin) approved by the FDA but all applications have been withdrawn. Genentech pioneered the use of recombinant human growth hormone for human therapy...

Word Count : 6621

Omalizumab

Last Update:

partnership. Having failed to receive reconciliation from Genentech, Tanox filed a lawsuit against Genentech for trade secret violation. Coincidentally, Tanox...

Word Count : 4909

Annual pharmaceutical drug sales

Last Update:

[1], Genentech 2008 10-K. [2], Pfizer 2008 10-K. [3], Eli Lilly & Co. 2008 10-K. [4], Allergan 2008 10-K. [5], Merck 2008 10-K. [6], Ista Pharmaceuticals...

Word Count : 229

Risdiplam

Last Update:

PTC Therapeutics and the SMA Foundation, it is marketed in the US by Genentech, a subsidiary of Roche. In the United States, risdiplam is indicated to...

Word Count : 1772

Pertuzumab

Last Update:

promote cell growth and proliferation. It was discovered and developed by Genentech and was first approved in 2012. Pertuzumab is administered as an intravenous...

Word Count : 2121

Novartis

Last Update:

over Roche. Novartis also has two significant license agreements with Genentech, a Roche subsidiary. One agreement is for Lucentis; the other is for Xolair...

Word Count : 11963

Monoclonal antibody therapy

Last Update:

colitis Plaque psoriasis 761024 Link ado-trastuzumab emtansine Kadcyla Genentech 2/22/2013 intravenous humanized, antibody-drug conjugate HER2 Metastatic...

Word Count : 4064

Oregon

Last Update:

Torvalds, developer of the Linux kernel. In 2010, biotechnology giant Genentech opened a $400 million facility in Hillsboro to expand its production capabilities...

Word Count : 16683

DPR Construction

Last Update:

Prineville Data Center (Prineville, Oregon) Genentech, Oceanside Production Operations (Oceanside, California) Genentech, Cell Culture Plant 2 (CCP-2) (Vacaville...

Word Count : 1305

Don Francis

Last Update:

served as the Chair of the Mayor's HIV Task Force. In 1993, Francis joined Genentech, Inc., of South San Francisco to try to develop a vaccine for HIV. In...

Word Count : 770

Diazepam

Last Update:

Diazepam, sold under the brand name Valium among others, is a medicine of the benzodiazepine family that acts as an anxiolytic. It is used to treat a range...

Word Count : 9983

Vishva Dixit

Last Update:

Indian origin who is the current Vice President of Discovery Research at Genentech. Vishva Dixit was born in Kenya in 1956. His parents were both physicians...

Word Count : 3462

David Ebersman

Last Update:

Health. He previously served as chief financial officer of Facebook and Genentech. At Facebook, Ebersman orchestrated the largest U.S. Internet IPO of all...

Word Count : 586

History of biotechnology

Last Update:

finally announced in September 1978 and was produced by a startup company, Genentech. Although that company did not commercialize the product themselves, instead...

Word Count : 4708

William Rastetter

Last Update:

(1979–1981) and an Alfred P. Sloan Fellowship (1980–1982). Rastetter joined Genentech Inc. in 1982 as a scientist, and directed its Biocatalysts and Chemical...

Word Count : 2503

List of drugs granted breakthrough therapy designation

Last Update:

Atezolizumab Genentech alveolar soft part sarcoma Adagrasib Mirati Therapeutics KRAS G12C-mutated non-small cell lung cancer Mosunetuzumab Genentech follicular...

Word Count : 180

June Lee

Last Update:

General Hospital. She maintained an independent research program prior to Genentech, funded by the American Lung Association, to investigate IL-13 induced...

Word Count : 697

Seagen

Last Update:

including AbbVie, Bayer Celldex Therapeutics, Inc., Daiichi Sankyo, Genentech, Inc., GlaxoSmithKline, Pfizer, Inc., and PSMA Development Company LLC...

Word Count : 3140

PDF Search Engine © AllGlobal.net